Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.4 mg for weight management
Bagsværd, Denmark 18 December 2020 – Novo Nordisk today announced the submission of a Marketing…
News
Mesoblast Webcast – Update on COVID-19 ARDS Trial
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
The Financial Calendar of JSC “Grindeks” for the year of 2021
The Financial Calendar of JSC “Grindeks” for the year of 2021 JSC “Grindeks” plans…
OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine
CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in…
Editas Medicine Names Meeta Chatterjee, Ph.D., to Board of Directors
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ: EDIT), a leading…
Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%
PRESS RELEASE December 17, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Availability of the Q4 2020 Memorandum for modelling purposes
Availability of the Q4 2020 Memorandum for modelling purposes Paris, France – December 17,…
Mesoblast Update on COVID-19 ARDS Trial
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today provided an…
VistaGen Therapeutics Announces Proposed Underwritten Public Offering
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
PRA’s remote patient monitoring (RPM) solution now offers a suite of COVID-19 tools – diagnostic…